Share on LinkedInShare on LinkedIn

ARTICLE · 26 NOVEMBER 2019

How Pending Cannabis Legislation Could Impact Your Business

The House Judiciary Committee on Nov. 20 voted 24-10 to advance the Marijuana Opportunity Reinvestment and Expungement Act, or the "MORE" Act (the Act)

United StatesCannabis & Hemp

The House Judiciary Committee on Nov. 20 voted 24-10 to advance the Marijuana Opportunity Reinvestment and Expungement Act, or the "MORE" Act (the Act). As referenced in a recent Law360 article, the overarching goal of the Act is to decriminalize and normalize cannabis. The Act would provide relief to two main groups of individuals: (1) cannabis business owners; and (2) individuals with cannabis convictions. Our focus is on the Act's potential benefits for and effect on current and future cannabis business owners.

The Act's removal of cannabis containing THC from the controlled substances list would alleviate numerous barriers for cannabis businesses. One of these obstacles is the dreaded section 280E of the Internal Revenue Code, which prohibits business deductions for businesses “trafficking” in substances listed on either Schedule I or II of the Controlled Substances Act. Cannabis is currently listed as a Schedule I controlled substance. Because of this,

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from